Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2005
08/31/2005EP1568779A1 HSV strains for the oncolytic treatment of cancer
08/31/2005EP1568699A1 1,3-dihydroimidazole fused-ring compound
08/31/2005EP1568697A1 1,3-benzothiazinone derivatives, process for producing the same and use thereof
08/31/2005EP1568695A1 3,4-Dihydroquinazoline derivatives as T-type calcium channel blockers and method of preparing the same
08/31/2005EP1568685A1 Aminoadamantane derivatives as therapeutic agents
08/31/2005EP1567667A1 Treatment of huntington's disease with epa
08/31/2005EP1567511A1 Substituted piperazines, (1,4) diaszepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
08/31/2005EP1567502A1 Substituted dihydrophenanthridinesul fonamides
08/31/2005EP1567501A1 Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors
08/31/2005EP1567496A1 Phenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain or gastrointestinal disorders
08/31/2005EP1567488A1 Hydroxyethylamine derivatives for the treatment of alzheimer's disease
08/31/2005EP1567487A2 Open chain prolyl urea-related modulators of androgen receptor function
08/31/2005EP1567186A2 Nogo, caspr, f3 and nb-3 useful in the treatment of injury and disease to the central nervous system
08/31/2005EP1567182A2 Preventing desensitization of receptors
08/31/2005EP1567180A2 Methods of treating cognitive dysfunction by modulating brain energy metabolism
08/31/2005EP1567177A2 Mucuna pruriens and extracts thereof for the treatment of neurological diseases
08/31/2005EP1567164A1 Use of loxapine or amoxapine for the manufacture of a medicament for the treatment of pain
08/31/2005EP1567159A1 Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions
08/31/2005EP1567152A2 Use of rasagiline with or without riluzole to treat amyotrophic lateral sclerosis
08/31/2005EP1567150A1 Derivatives of indole-3-carboxamide, preparation method thereof and application of same in therapeutics
08/31/2005EP1567146A1 Iontophoretic delivery of rotigotine for the treatment of parkinson's disease
08/31/2005EP1567131A1 Bupropion hydrochloride solid dosage forms
08/31/2005EP1517914B1 9-alpha-substituted estratrienes as selectively active estrogen
08/31/2005EP1430057B1 Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido 1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo 1,2-a]pyrimidin-5(1h)one derivatives
08/31/2005EP1397359B1 1-biaryl-1,8-napthyridin-4-one phosphodiesterase-4 inhibitors
08/31/2005EP1395576B1 4-(phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestinal disorders
08/31/2005EP1390366B1 The citrate salt of 5,8,14,-triazatetracyclo(10.3.1.02,11.04,9)-hexadeca-2(11),3,5,7,9-pentaene
08/31/2005EP1379627A4 Method for differentiating mesenchymal stem cells into neural cells
08/31/2005EP1347978B1 Novel substituted imidazotriazinones as pde ii-inhibitors
08/31/2005EP1294381B1 Neuroprotective 7-beta-hydroxysteroids
08/31/2005EP1278723B1 P-(sulfonyl)-aryl and -heteroaryl amines
08/31/2005EP1240168B1 Bicyclic inhibitors of glycogen synthase kinase 3
08/31/2005EP1238059A4 Long-term cell culture compositions and genetically modified animals derived therefrom
08/31/2005EP1169060B1 Sodium channel blocker compositions and the use thereof
08/31/2005EP1163212B1 Amide derivatives
08/31/2005EP1156856B1 Use of fluorinated triazoles for the treatment of neuropathic pain
08/31/2005EP1156047B1 6-substituted-7- heteroquinoxaline carboxylic acid derivatives and addition salts thereof and processes for the preparation of both
08/31/2005EP1095020B1 2-aminopyridine erivatives, their use as medicines and pharmaceutical compositions containing them
08/31/2005EP1035833B1 Compositions for nasal administration
08/31/2005EP1003497B1 Il-8 receptor antagonists
08/31/2005EP0996731B1 Retroviral nucleic material and nucleotide fragments, in particular associated with multiple sclerosis and/or rheumatoid arthritis, for diagnostic, prophylactic and therapeutic uses
08/31/2005EP0973819B1 Non-antigenic branched polymer conjugates
08/31/2005CN1662664A Ldl receptor-related proteins 1 and 2 and treatment of bone or cartilage conditions
08/31/2005CN1662654A Preparation of microbial oil containing polyunsaturated fatty acids
08/31/2005CN1662645A Process for producing nerve cells
08/31/2005CN1662642A Pasteurisation process for microbial cells and microbial oil
08/31/2005CN1662554A Vaccine for the prevention and treatment of alzheimer's and amyloid related diseases
08/31/2005CN1662544A Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662542A Heterocyclic compounds
08/31/2005CN1662541A Furyl compounds
08/31/2005CN1662539A [1, 4]diazocino [7, 8, 1-hi]indole derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662538A Arylalkyl indoles having sertonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
08/31/2005CN1662534A 1, 2, 3, 4, 7, 8-hexahydro-6h-[1, 4]diazepino[6, 7, 1-1j]quinoline derivatives as antipsychotic and antiobesity agents
08/31/2005CN1662533A [1, 4]diazepino[6, 7, 1-ij]quinoline derivatives as anti psychotic and antiobesity agents
08/31/2005CN1662531A Hetero-bicyclic compounds
08/31/2005CN1662530A Azabicyclo-octane and nonane derivatives with DPP-IV inhibiting activity
08/31/2005CN1662528A Piperazine benzothiazoles as agents for the treatment of cerebral ischemic disorders or cns disorders
08/31/2005CN1662524A Indole derivatives useful as histamine h3 antagonists
08/31/2005CN1662523A Novel process
08/31/2005CN1662522A Novel compounds, their use and preparation
08/31/2005CN1662521A Compounds useful for the treatment of obesity, type ii diabetes and cns disorders
08/31/2005CN1662519A Heterocyclic compounds as glycine transport inhibitors
08/31/2005CN1662516A N, N-disubstituted diazocycloalkanes
08/31/2005CN1662513A 2-thioxothiazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/31/2005CN1662511A Pharmaceutical salts of reboxetine
08/31/2005CN1662506A Methods and compositions for treatment of central and peripheral nervous system disorders and novel compounds useful therefor
08/31/2005CN1662505A Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same
08/31/2005CN1662501A Cyanoguanidine prodrugs
08/31/2005CN1662497A Derivative of n-[phenyl(piperidin-2-yl)methyl]benzamide, the preparation method thereof and application of same in therapeutics
08/31/2005CN1662496A Cannabinoid receptor agonists
08/31/2005CN1662490A Nitrooxyderivatives of cyclooxygenase-2 inhibitors
08/31/2005CN1662249A Osteopontin, oligodendrocytes and myelination
08/31/2005CN1662246A Combination therapy wherein a serotonin reuptake inhibitor is used
08/31/2005CN1662245A (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
08/31/2005CN1662242A Pharmaceutical compositions for the treatment of diseases related to neurotrophines
08/31/2005CN1662236A Inhibitors of histone deacetylase
08/31/2005CN1662232A Medicinal compositions improving brain function and method for improving brain function
08/31/2005CN1662231A Prevention and treatment of functional somatic disorders, including stress-related disorders
08/31/2005CN1662226A Monocompartment osmotic controlled drug delivery system
08/31/2005CN1662222A Free-flowing, powdery composition containing alpha-liponic acid (-derivatives)
08/31/2005CN1660849A Pyridine and pyrimidine derivatives and their use as inhibitors of cytokine mediated disease
08/31/2005CN1660840A Phthalazine derivatives for treating inflammatory diseases
08/31/2005CN1660839A Chemical compounds
08/31/2005CN1660834A Compound containing o-naphthaquinone and application
08/31/2005CN1660833A Compound containing structure of o-naphthaquinone and application
08/31/2005CN1660820A 3, 4-dihydroquinazoline derivatives as t-type calcium channel blockers and method of preparing the same
08/31/2005CN1660815A Cyclic amine derivatives and their use as drugs
08/31/2005CN1660779A Mono- and disubstituted 3-propyl gamma-aminobutyric acids
08/31/2005CN1660435A New drug combinations
08/31/2005CN1660427A Extracorporeal photopheresis in combination with anti-tnf treatment
08/31/2005CN1660400A Medication for improving sleep
08/31/2005CN1660398A Combination of medication for treating sleep disorder
08/31/2005CN1660392A 'Changyuan' capsule and preparing techniue
08/31/2005CN1660386A Health care wine and preparation method
08/31/2005CN1660366A Notoginseng floral leaf drop pill in use for cleaning away heat and its prepn. process
08/31/2005CN1660361A Cold drop pills of mulberry and ginger in use for eliminating draft, clearing away heat, and preparing method
08/31/2005CN1660352A Combination of medication of possessing synergetic effect
08/31/2005CN1660351A Combination of medication of containing astragalus root and dragon's blood resin and application
08/31/2005CN1660347A Yinhuang combination, oral taking preparation and injection preparation, preparing method and application
08/31/2005CN1660315A Chinese traditional medicine for treating neuralgia
1 ... 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 965 966 ... 1833